Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19
Luis H. Paz Rios(NorthShore University HealthSystem), Alfonso Tafur(NorthShore University HealthSystem), Elizabeth Lees(NorthShore University HealthSystem), Amit Pursnani(NorthShore University HealthSystem), Joseph A. Caprini(Northwestern University), Ashley Aller(NorthShore University HealthSystem), Victor Macrinici(NorthShore University HealthSystem), Iva Minga(University of Chicago), Ayman Najib(NorthShore University HealthSystem), Esther Kwak(NorthShore University HealthSystem), Kaveh Rezaei Bookani(NorthShore University HealthSystem), Alex C. Spyropoulos(Lenox Hill Hospital)
Cited by 11
Related Papers
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
|European Heart Journal|2014|3.1k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH
|Journal of Thrombosis and Haemostasis|2015|1.4k
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
|New England Journal of Medicine|2015|1.2k
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
|New England Journal of Medicine|2013|603